Thus, we tested and quantified the presence of BDNF, VEGFC, VEGFR3, and EMAP‐II effectors of ∆Np73 in plasma from CRC patients, patients with premalignant lesions and controls using commercially available ELISAs (Fig. 3; Fig. S3). The gene discussed is FLT4; the disease is colorectal carcinoma.